Delhi High Court restrains GLENMARK’S INDAMET in trademark infringement suit by Sun Pharma’s ISTAMET

Brief Facts: The Delhi High Court recently decided a trade mark case in CS(COMM) 711/2022, where Sun Pharma Laboratories Ltd. (the Plaintiff) filed an infringement suit against Glenmark Pharmaceuticals Ltd. (the Defendant) over the latter’s use of the mark “INDAMET,” which Sun Pharma argued was deceptively similar to its own mark “ISTAMET.” Plaintiff’s Contentions: Sun…